Medical devices cover an array products from consumable items to innovative implants and appliances, each serving a particular application or therapeutic area. The medical devices market has seen seismic changes with regional regulations, downwards pricing pressures and advancement in technological standards, equipment and procedures. A&M supports medical device companies in addressing critical objectives with our seasoned industry operators and results-driven approach.
To help deliver sustainable value creation, we support medical device companies and investors in the following areas:
- M&A Strategy, Carve-Outs & Synergy Capture
- Product Innovation & Launch
- Pricing & Reimbursements
- Business Unit / Model Re-design
- Product Margin Improvement
- Sales & Marketing Effectiveness
- Supply Chain Operations
- R&D and Portfolio Review
- Quality Control, Improvement & Compliance
- Regulatory Compliance
- Operating Cost & Working Capital Optimisation
We support a broad range of medical device developers, manufacturers and distributors, our experience covers the following specialist areas:
- Medical Imaging
- In-Vitro Diagnostics
- Orthopaedic Implants & Equipment
- Surgical Equipment & Supplies
- Aesthetic Devices
- Dental
- Ophthalmology
- ENT
- Distributors & Wholesalers
Contract Research Organisations M&A Market
March 28, 2025
Rising cost pressures, stricter regulatory demands and advancements in emerging therapeutics are intensifying competition within the industry. These dynamics are fuelling the demand for greater efficiency in development lifecycles, creating significant opportunities for outsourced providers like Contract Research Organisations (CROs).
Healthcare Workforce Predictions for 2025
March 19, 2025
The healthcare landscape in 2025 is marked by a complex interplay of financial pressures, persistent workforce shortages, and rapid technological advancements. While healthcare providers have stabilized post-pandemic, they face shrinking revenues coupled with escalating workforce expense, which now comprise a significant portion of total expenses.
Mass General Brigham is Redefining ROI Through the Lens of its Mission to Improve Human Health
March 18, 2025
How do you fundamentally redefine “ROI”? Niyum Gandhi, CFO of Mass General Brigham, the largest employer in New England and the largest medical research organization in the world, shares about his Moonshot to do just that.
The Clock is Ticking: Why Health Plans Must Act Now to Maximize Star Ratings Before the 2026 HEI Update
March 12, 2025
The October 2026 Star Ratings release presents both an opportunity and a challenge for health plans as they navigate uncertain Health Equity Index (HEI) changes. With evolving CMS equity-focused metrics, shifting data collection requirements, and potential weighting adjustments, health plans must take immediate action to optimize their Star Ratings before potential regulatory shifts in 2027.
